Dr. Yong-Soo Bae is a professor of the Department of Biological Science at College of Natural Science, Sungkyunkwan University. He is the ex-president of Korean Society for Virology and a vice president of the Korean Vaccine Society. He graduated in the Department of Microbiology at Seoul National University in 1981, and obtained a Master’s degree from the same University Graduate School. He finished his Ph.D from the University of Calgary, Faculty of Medicine in 1990. He took his post-Dr trainings in the field of dendritic cells and AIDS pathogenesis at Dana-Farber Cancer Institute, Harvard Medical School. He founded the Korean Society for Dendritic Cell Research and has devoted himself to building-up of the Society. He invited and organized 12th International Dendritic Cell Symposium in Korea, DC2012 (www.DC2012.kr, Meeting report http://www.ncbi.nlm.nih.gov/pubmed/23525839 ). His current research focuses on DC immunotherapy, DC subsets and differentiation from hematopoietic stem cells and DC-mediated immune homeostasis in vivo. His Lab is also interested in viral pathogenesis and development of therapeutic mucosal vaccines using poliovirus Sabin 1 as a vaccine vector. His group published 87 original papers in peer-reviewed journal.
Yong-Soo Bae's Social Media
Home Page: http://shb.skku.edu/skkuvirus/
Research Gate https://www.researchgate.net/profile/Yong-Soo_Bae
PubMed:https://www.ncbi.nlm.nih.gov/pubmed/pubmed?cmd=search&db=PubMed&term=Yong-Soo+Bae
linkedin https://www.linkedin.com/in/yong-soo-bae-32051b27
DC2016: Plenary speaker; http://www.dc-2016.com/en/news.asp?id=51.html
skku 구 홈패이지 http://skkuvirus.dothome.co.kr/index.html
I am interested in following three research fields:
1) As a first project, we have been focusing on the molecular differentiation of DC subsets from bone marrow progenitor cells and their immunogenicity and immune regulation. 2) Second project is the study on the role and functions of p53 and PKR under stress conditions, such as HIV-1 infection, genotoxic stresses, inflammatory stresses etc 3) Third project is a development of mucosal CTL vaccines using poliovirus vector system. |